SAMN30312320
External Id
Doug Higgs, Weatherall Institute of Molecular Medicine, University of Oxford
INSDC center name
2022-08-18T00:50:19.207Z
INSDC first public
2022-08-18T00:50:19.207Z
INSDC last update
SRS14649168
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS14649168
SRA accession
Primary erythroid cells derived from spleen from INVEN APH-treated mice are disaggregated and cells stained with ter119-PE antibody (BD Biosciences at a working concentration of 2ug/ml) then incubated with anti-PE MACS beads (Miltenyi) and purified using LS columns (Miltenyi), all following manufacturor's instructions.
cell type
Ter119+ erythroid cells purified from the spleen of an INVEN Phenylhydrazine APH-treated mice, sample 1
cell type
CTCF: Merck Millipore 07-729 at 5ug/ml
chip antibody
Mus musculus
http://purl.obolibrary.org/obo/NCBITaxon_10090
organism
mouse derived Erythroid cells
source_name
C57Bl8
strain
APHSpleen_INVEN_Ter119_CTCF_1
title
Genome-wide
treatment